First-of-Kind Kidney Injury Risk Test

The FDA has approved NephroCheck test, a first-of-a-kind lab test to assist in determining if some hospital patients are at risk of developing AKI.

Testosterone Benefits, Risks Reviewed

An FDA review was released in advance of a public meeting to discuss the benefits and risks of treatments to boost men's testosterone levels.

Tamsulosin for Recurrent UTI in Women

A new study suggests that tamsulosin may be an effective treatment option for women with dysfunctional voiding and recurrent UTI.

DVT, PE Rare After Urological Surgery

Deep venous thrombosis (DVT) and pulmonary embolism (PE) are uncommon after urological surgery, reports a new study.

Pumpkin Seed for LUTS in Men? ...

In men with LUTS and BPH, treatment with pumpkin seed led to clinically relevant IPSS reductions compared to placebo.

Physical Activity, Nocturia Inversely Linked

Men who are physically active are less likely to report nocturia, commonly associated with benign prostatic hyperplasia (BPH).

Atypical Antipsychotics, Renal Injury Risk

Use of atypical antipsychotic drugs is associated with increased risk of acute kidney injury (AKI) in older adults.

Chart: BPH Treatments

Review this chart on BPH Treatments for quick information when you need it.

News

Limited Benefits with Fenoldopam Seen After Cardiac Sx

For critically ill cardiac surgery patients, fenoldopam does not reduce the need for renal replacement therapy, according to a new study.

Despite FDA Warning, No OSP-Acute Kidney Injury Risk Link Seen in New Study

Use of oral sodium phosphate (OSP) for bowel cleansing prior to a colonoscopy is not associated with the risk of postprocedure acute kidney injury (AKI).

CKD Doesn't Bar Thrombolytic Therapy in Stroke

Intravenous (IV) thrombolytic therapy for acute ischemic stroke (IS) is not contraindicated in patients with chronic kidney disease (CKD).

Efficacy of Oral Testosterone in Hypogonadal Men Demonstrated in Study

Lipocine announced top-line results from its Phase 3 SOAR clinical trial evaluating the efficacy and safety of LPCN 1021, an oral testosterone agent in hypogonadal men with low testosterone.

Obesity, Endocrine Disruptors Linked to Early Puberty

In a recent opinion article, Dr. Laurence Steinberg describes the association between the obesity rate among children in the U.S. and the falling age of the onset of puberty.

FEATURES

How to Start a Subspecialty Clinic

How to Start a Subspecialty Clinic

In-house clinics can be a cost-efficient way to provide high-quality healthcare, without having to make a large investment.

Experts Weigh In: Omega-3s and Prostate Cancer

Experts Weigh In: Omega-3s and Prostate Cancer

Some researchers are not convinced that high blood levels of omega-3 fatty acids are associated with an increased PCa risk.

Prostate Cancer Diagnosis: Understanding Symptoms and Screening

Prostate Cancer Diagnosis: Understanding Symptoms and Screening

Prostate cancer is the most common male-related malignancy in the US, the second most common cause of cancer-related death among men.

Featured courses from mycme

Improving Quality of Life and Total Health in Men with HypogonadismExternal web site

Today many men are seeking information and treatment for hypogonadism, often to address issues of ...

CME|CE 1.00 Credits

Shared Decision Making in Managing Idiopathic and Neurogenic OABExternal web site

Data suggest that clinicians often fail to communicate adequately with patients to select individualized therapy. ...

CME 1.00 Credits

FSGS: Talking Points for the Practicing NephrologistExternal web site

From the July 2014 issue of Renal and Urology News: Primary focal segmental glomerulosclerosis (FSGS) ...

CME 1.00 Credits

Sign Up for Free e-newsletters